Ligand Pharma (LGNYZ) Stock Price, News & Analysis
Company Description
Ligand Pharma (OTC Link: LGNYZ) is a publicly traded company.
LGNYZ stock has gained 37.6% over the past year. Shares last traded at $0.0515.
On a trailing twelve-month basis, Ligand Pharma reported revenue of $268.1M with net income of $124.5M and diluted earnings per share of $6.13. The company operates at a net profit margin of 46.4%.
This page provides a comprehensive overview of LGNYZ stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ligand Pharma (LGNYZ) stock last traded at $0.0515, up 4.65% from the previous close. Over the past 12 months, the stock has gained 37.6%.
LGNYZ Rankings
Latest News
SEC Filings
Ligand Pharma has filed 5 recent SEC filings, including 3 Form 4, 1 Form 144, 1 Form 8-K. The most recent filing was submitted on July 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LGNYZ SEC filings →
Financial Highlights
Ligand Pharma generated $268.1M in revenue over the trailing twelve months, operating income reached $41.0M (15.3% operating margin), and net income was $124.5M, reflecting a 46.4% net profit margin. Diluted earnings per share stood at $6.13. The company generated $49.4M in operating cash flow. With a current ratio of 22.23, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Ligand Pharma (LGNYZ) currently stands at 55.7 thousand shares, down 1.3% from the previous reporting period, representing 0.3% of the shares outstanding. Over the past 12 months, short interest has increased by 1454.5%.
Days to Cover History
Days to cover for Ligand Pharma (LGNYZ) currently stands at 1.2 days, down 89.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 24% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.